PictorLabs emerged from stealth mode Thursday with $15 million to advance its AI-powered virtual staining platform that researchers hope will “reimagine the future” of histopathology.
https://www.pharmalive.com/wp-content/uploads/2022/12/microscope.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-12-01 09:46:362022-12-01 09:46:48PictorLabs reimagines Histopathology with AI, starting with cancer
